ORIC (STOCKS)
Oric Pharmaceuticals, Inc. Common Stock
$10.400000
+0.250000 (+2.46%)
Prev close: $10.150000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jacob M. Chacko
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,042.72M
- Employees
- 128
- P/E (TTM)
- -6.87
- P/B (TTM)
- 2.60
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $13.54M |
| Operating Expenses | $143.00M |
| Operating Income/Loss | -$143.00M |
| Income/Loss From Continuing Operations After Tax | -$129.47M |
| Income/Loss From Continuing Operations Before Tax | -$129.47M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$129.47M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$129.47M |
| Net Income/Loss Available To Common Stockholders, Basic | -$129.47M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.47 |
| Diluted Earnings Per Share | -$1.47 |
| Basic Average Shares | 87,793,801 |
| Diluted Average Shares | 87,793,801 |
| Assets | $408.89M |
| Current Assets | $288.47M |
| Noncurrent Assets | $120.42M |
| Fixed Assets | $2.42M |
| Other Non-current Assets | $118.01M |
| Liabilities | $24.53M |
| Current Liabilities | $20.42M |
| Accounts Payable | $3.82M |
| Other Current Liabilities | $16.59M |
| Noncurrent Liabilities | $4.11M |
| Equity | $384.36M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $384.36M |
| Liabilities And Equity | $408.89M |
| Net Cash Flow From Operating Activities | -$110.97M |
| Net Cash Flow From Operating Activities, Continuing | -$110.97M |
| Net Cash Flow From Investing Activities | -$148.03M |
| Net Cash Flow From Investing Activities, Continuing | -$148.03M |
| Net Cash Flow From Financing Activities | $245.26M |
| Net Cash Flow From Financing Activities, Continuing | $245.26M |
| Net Cash Flow | -$13.74M |
| Net Cash Flow, Continuing | -$13.74M |
| Comprehensive Income/Loss | -$129.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$129.06M |
| Other Comprehensive Income/Loss | $407.00K |